As part of the settlement, Fresenius, a German-based dialysis clinic operator, admitted to paying bribes to officials in Saudi Arabia and Angola between 2007 and 2016. During that time, the company also failed to implement proper internal accounting controls over financial transactions in several countries, including Angola, Saudi Arabia, Morocco, Spain and Turkey.
“Fresenius doled out millions of dollars in bribes across the globe to gain a competitive advantage in the medical services industry, profiting to the tune of over $140 million,” Assistant Attorney General Brian Benczkowski said in a press release.
To resolve the case, Fresenius entered into a nonprosecution agreement with the Justice Department and agreed to pay a criminal penalty of $84.7 million. The company also agreed to pay the Securities and Exchange Commission $147 million to settle a related Foreign Corrupt Practices Act matter.
More articles on legal and regulatory issues:
13 latest healthcare industry lawsuits, settlements
Ex-biotech CFO sentenced to prison for embezzlement
West Virginia hospital, CEO hit with kickback suit
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
